References
- Ben-Aharon, I., Gafter-Gvili, A., Leibovici, L., & Stemmer, S.M. (2010). Pharmacological interventions for fertility preservation during chemotherapy: A systematic review and meta-analysis. Breast Cancer Research and Treatment, 122, 803–811. doi: https://doi.org/10.1007/s10549-010-0996-7.
- Cakmak, H., & Rosen, M.P. (2015). Random-start ovarian stimulation in patients with cancer. Current Opinion in Obstetrics and Gynecology, 27, 215–221. doi: https://doi.org/10.1097/gco.0000000000000180.
- Cancer Research UK. (2011–2013). Cancer Research UK. Retrieved from http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/age#heading-Zero.
- Cancer Research UK. (2015). Cancer survival statistics. Retrieved from http://www.cancerresearchuk.org/health-professional/cancer-statistics/survival.
- de Pedro, M., Otero, B., & Martin, B. (2015). Fertility preservation and breast cancer: A review. Ecancermedicalscience, 9, 503. doi: https://doi.org/10.3332/ecancer.2015.503.
- Glujovsky, D., Riestra, B., Sueldo, C., Fiszbajn, G., Repping, S., Nodar, F., … Ciapponi, A. (2014). Vitrification versus slow freezing for women undergoing oocyte cryopreservation. Cochrane Database of Systematic Reviews, 9, Cd010047. doi: https://doi.org/10.1002/14651858.CD010047.pub2.
- Green, D.M., Sklar, C.A., Boice, J.D., Jr., Mulvihill, J.J., Whitton, J.A., Stovall, M., & Yasui, Y. (2009). Ovarian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 27, 2374–2381. doi: https://doi.org/10.1200/JCO.2008.21.1839.
- HFEA. (2016). Fertility treatment in 2014: Trends and figures. Retrieved from http://www.hfea.gov.uk/10243.html.
- Lord, J., Shaw, L., Dobbs, F., & Acharya, U. (2001). A time for change and a time for equality–infertility services and the NHS. Human Fertility, 4, 256–260. doi: https://doi.org/10.1080/1464727012000199621.
- Lower, E.E., Blau, R., Gazder, P., & Tummala, R. (1999). The risk of premature menopause induced by chemotherapy for early breast cancer. Journal of Women's Health and Gender-Based Medicine, 8, 949–954. doi: https://doi.org/10.1089/jwh.1.1999.8.949.
- Magelssen, H., Melve, K.K., Skjaerven, R., & Fossa, S.D. (2008). Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood. Human Reproduction, 23, 178–186. doi: https://doi.org/10.1093/humrep/dem362.
- Mahajan, N. (2015). Fertility preservation in female cancer patients: An overview. Journal of Human Reproductive Sciences, 8, 3–13. doi: https://doi.org/10.4103/0974-1208.153119.
- NICE. (2013). NICE Guidelines Fertility [CG156]: Assessment and treatment for people with fertility problems. Retrieved from https://www.nice.org.uk/guidance/cg156.
- Office for National Statistics. (2014). Cancer registration statistics, England, 2014. Retrieved from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/cancerregistrationstatisticscancerregistrationstatisticsengland.
- Oktay, K., & Sonmezer, M. (2008). Chemotherapy and amenorrhea: Risks and treatment options. Current Opinion in Obstetrics and Gynecology, 20, 408–415. doi: https://doi.org/10.1097/GCO.0b013e328307ebad.
- Pacey, A.A., & Eiser, C. (2011). Banking sperm is only the first of many decisions for men: What healthcare professionals and men need to know. Human Fertility, 14, 208–217. doi: https://doi.org/10.3109/14647273.2011.634480.
- Peddie, V.L., Porter, M.A., Barbour, R., Culligan, D., MacDonald, G., King, D., … Bhattacharya, S. (2012). Factors affecting decision making about fertility preservation after cancer diagnosis: A qualitative study. BJOG, 119, 1049–1057. doi: https://doi.org/10.1111/j.1471-0528.2012.03368.x.
- Porter, M.B. (2008). Ultrasound in assisted reproductive technology. Seminars in Reproductive Medicine, 26, 266–276. doi: https://doi.org/10.1055/s-2008-1076145.
- Revel, A., & Revel-Vilk, S. (2010). Fertility preservation in young cancer patients. Journal of Human Reproductive Sciences, 3, 2–7. doi: https://doi.org/10.4103/0974-1208.63113.
- Royal College of Physicians, The Royal College of Radiologists, & Royal College of Obstetricians and Gynaecologists. (2007). The effects of cancer treatment on reproductive functions: Guidance on management. Report of a Working Party. Retrieved from https://www.rcr.ac.uk/sites/default/files/publication/Cancer_fertility_effects_Jan08.pdf.
- Salama, M., & Mallmann, P. (2015). Emergency fertility preservation for female patients with cancer: Clinical perspectives. Anticancer Research, 35, 3117–3127. Retrieved from http://ar.iiarjournals.org/content/35/6/3117.abstract.
- Salih, S.M., Albayrak, S., Seo, S., Stewart, S.L., Bradley, K., & Kushner, D.M. (2015). Diminished utilization of in vitro fertilization following ovarian transposition in cervical cancer patients. Journal of Reproductive Medicine, 60, 345–353. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869987/.
- Sekeres, M.A., Elson, P., Kalaycio, M.E., Advani, A.S., Copelan, E.A., Faderl, S., … Estey, E. (2009). Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood, 113, 28–36. doi: https://doi.org/10.1182/blood-2008-05-157065.
- Smith, G.D., Serafini, P.C., Fioravanti, J., Yadid, I., Coslovsky, M., Hassun, P., … Motta, E.L. (2010). Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertility and Sterility, 94, 2088–2095. doi: https://doi.org/10.1016/j.fertnstert.2009.12.065.
- Thomas-Teinturier, C., Allodji, R.S., Svetlova, E., Frey, M.A., Oberlin, O., Millischer, A.E., … De Vathaire, F. (2015). Ovarian reserve after treatment with alkylating agents during childhood. Human Reproduction, 30, 1437–1446. doi: https://doi.org/10.1093/humrep/dev060.
- Tucker, M., & Liebermann, J. (2015). Vitrification in Assisted Reproduction (2nd ed.). New York: Taylor & Francis Books Ltd., 2015, pp. 1–22.
- Turan, V., & Oktay, K. (2014). Sexual and fertility adverse effects associated with chemotherapy treatment in women. Expert Opinion on Drug Safety, 13, 775–783. doi: https://doi.org/10.1517/14740338.2014.915940.
- von Wolff, M., Capp, E., Jauckus, J., Strowitzki, T., Germeyer, A., & FertiPROTEKT study group. (2016). Timing of ovarian stimulation in patients prior to gonadotoxic therapy: An analysis of 684 stimulations. European Journal of Obstetrics, Gynecol Ogy and Reproductive Biology, 199, 146–149. doi: https://doi.org/10.1016/j.ejogrb.2016.02.006.
- Waimey, K.E., Smith, B.M., Confino, R., Jeruss, J.S., & Pavone, M.E. (2015). Understanding fertility in young female cancer patients. Journal of Womens Health (Larchmt), 24, 812–818. doi: https://doi.org/10.1089/jwh.2015.5194.